Esmolol is a short-acting beta-blocker primarily used to control heart rate and blood pressure, particularly during surgery or in critical care settings. Its patent status influences its market availability and pricing. Information on the specific patents for Esmolol and their expiration dates can be found through resources like DrugPatentWatch.com [1].
When does Esmolol's patent protection end?
Patent expiration dates are crucial for determining when generic versions of a drug can enter the market. For Esmolol, the original patents have long since expired, allowing for the production of generic formulations. DrugPatentWatch.com tracks these patent landscapes for various pharmaceuticals [1].
How does generic Esmolol affect pricing?
The availability of generic Esmolol typically leads to a significant reduction in cost. When a branded drug's patent expires, multiple manufacturers can produce and sell generic versions, increasing competition and driving down prices for healthcare providers and patients [1].
What is Esmolol used for?
Esmolol is indicated for the rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter in perioperative, postoperative, or other situations where short-term control of the ventricular rate is desirable. It is also used for the treatment of supraventricular tachycardia and for the long-term management of patients with angina pectoris where a rapid-acting beta-blocker is indicated [2]. Its short half-life makes it particularly useful when rapid titration and discontinuation are needed [3].
What are the risks associated with Esmolol?
Like other beta-blockers, Esmolol can cause side effects. These may include hypotension, bradycardia, dizziness, and headache. Patients with certain pre-existing conditions, such as asthma or heart failure, may be at higher risk for adverse events [2]. Careful monitoring is required during administration.
Are there alternatives to Esmolol?
Other beta-blockers, such as metoprolol or atenolol, can be used for similar indications, although their pharmacokinetic profiles differ. Calcium channel blockers may also be considered in certain situations [2]. The choice of agent depends on the specific clinical scenario and patient characteristics.
Who manufactures Esmolol?
Both branded and generic versions of Esmolol are available. Major pharmaceutical companies and generic drug manufacturers produce Esmolol. Specific manufacturers can be identified by consulting drug databases and wholesalers.
Sources:
[1] https://drugpatentwatch.com/
[2] https://www.drugs.com/esmolol.html
[3] https://www.ncbi.nlm.nih.gov/books/NBK542196/